Uncategorized

How Brand-Name Drug Companies Delay Generic Competition: Product Hopping, Patent Thickets, and Market Exclusivity Tactics Explained

Brand-name drug companies dont always block generics with a single big patent. They often delay competition with a whole portfolio of smaller moveslayered over yearsuntil the generic window finally opens.
Thats the core theme behind the latest deep d…

How Brand-Name Drug Companies Delay Generic Competition: Product Hopping, Patent Thickets, and Market Exclusivity Tactics Explained Read Post »

Biotechblog
Scroll to Top